Table 33.8. Adjuvant tamoxifen in postmenopausal women (after exclusion of women with ER-poor disease): data from the 1998 overview analysis
| Table 33.8. Adjuvant tamoxifen in postmenopausal women (after exclusion of women with ER-poor disease): data from the 1998 overview analysis. | ||||
| Number of patients | ||||
|
Age group (years) |
5 years tamoxifen |
Controls |
Proportional reduction in recurrence (SD) |
Proportional reduction in mortality (SD) |
| 50-59 | 1285 | 1251 | 37% (6) | 11% (8) |
| 60-69 | 1606 | 1568 | 54% (5) | 33% (6) |
| ≥70 | 186 | 204 | 54% (13) | 34% (13) |
| Overall (includes <50) | 3738 | 3689 | 47% (3) | 26% (4) |
| Source: From the Early Breast Cancer Trialists: Collaborative Group,165 with permission. | ||||